Condition: Acute Myeloid Leukemia · Sponsor: Hutchmed
This study is a multicenter, randomized, open-label, phase III clinical study (RAPHAEL) to evaluate the efficacy, safety, and PK of HMPL-306 versus salvage chemotherapy in patients with R/R AML harboring IDH1 and IDH2 mutations.
This description comes directly from the study's public registry record.
Erin Lou, Doctor · +86 21 2067 1942 · erinl@hutch-med.com
Yu Wang, Bachelor · (+86) 18058125909 · yuwang@hutch-med.com
Always discuss trial participation with your own doctor first.
| Anhui Provincial Hospital（The First Affiliated Hospital of U STC） | Hefei, Anhui, China | Recruiting |
| The First Affiliated Hospital of Anhui Medical University | Hefei, Anhui, China | Recruiting |
| The Second Hospital of Anhui Medical University | Hefei, Anhui, China | Recruiting |
| Peking University People's Hospital | Beijing, Beijing Municipality, China | Recruiting |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Recruiting |
| Fujian Medical University Union Hospital | Fuzhou, Fujian, China | Recruiting |
| The First Affilated Hospital of Fujian Medical University | Fuzhou, Fujian, China | Recruiting |
| Quanzhou First Hospital Affiliated to Fujian Medical University | Quanzhou, Fujian, China | Recruiting |
| The First Affiliated Hospital of Xiamen University | Xiamen, Fujian, China | Recruiting |
| Sun Yat-sen University Cancer Center | Guangzhou, Guangdong, China | Recruiting |
| Guangzhou First People's Hospital | Guangzhou, Guangdong, China | Recruiting |
| Nanfang Hospital，Southern Medical University | Guanzhou, Guangdong, China | Recruiting |
+ 41 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06387069